Atara Biotherapeutics is a biotechnology company based in South San Francisco that develops off-the-shelf T-cell immunotherapies. Its work centres on treatments for cancers and autoimmune conditions driven by the Epstein-Barr virus, including a therapy for a rare complication that can follow organ or bone marrow transplantation. The company also pursues cell therapy candidates aimed at solid tumours and autoimmune disease, and it works with academic and clinical partners to advance these programmes.
Atara Biotherapeutics, Inc. trades under the code 0HIY on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2910 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
57/100
Mixed trend against its averages.
See the numbers →
Above 200-day average6.1%
From 52-week high-56.1%
MomentumFair
56/100
Typical recent returns for this exchange.
See the numbers →
3-month return3.2%
6-month return67.1%
12-month, skipping last month-45.4%
Stability (higher is calmer)Weak
3/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)151.8%
Worst drawdown, 1 year (smaller is calmer)-78.1%
LiquidityWeak
11/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 4.018 – 19.050Daily closes, split-adjusted
Signals
50-day average9.211
200-day average7.670
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.604
Technical summary
Daily
Bearish
4 bullish · 1 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
9.06
Bearish
EMA 10
8.88
Bearish
SMA 20
9.06
Bearish
EMA 20
9.01
Bearish
SMA 50
9.21
Bearish
EMA 50
9.08
Bearish
SMA 100
9.30
Bearish
EMA 100
8.99
Bearish
SMA 200
7.67
Bullish
EMA 200
9.05
Bearish
Oscillators (daily)
RSI (14)
38.18
Neutral
MACD (12, 26)
-0.12
Bearish
Momentum (12)
-12.19
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-166.4
Bullish
Pivot points (classic, last session)
S3
7.37
S2
7.75
S1
7.95
Pivot
8.33
R1
8.53
R2
8.91
R3
9.10
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
